Genscript Biotech (HKSE:01548) Days Sales Outstanding : 69.02 (As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Genscript Biotech Days Sales Outstanding?

Genscript Biotech's average Accounts Receivable for the six months ended in Dec. 2023 was HK$1,324 Mil. Genscript Biotech's Revenue for the six months ended in Dec. 2023 was HK$3,500 Mil. Hence, Genscript Biotech's Days Sales Outstanding for the six months ended in Dec. 2023 was 69.02.

The historical rank and industry rank for Genscript Biotech's Days Sales Outstanding or its related term are showing as below:

HKSE:01548' s Days Sales Outstanding Range Over the Past 10 Years
Min: 56.85 Med: 79.02 Max: 325.65
Current: 63.05

During the past 10 years, Genscript Biotech's highest Days Sales Outstanding was 325.65. The lowest was 56.85. And the median was 79.02.

HKSE:01548's Days Sales Outstanding is ranked better than
57.22% of 893 companies
in the Biotechnology industry
Industry Median: 72.43 vs HKSE:01548: 63.05

Genscript Biotech's Days Sales Outstanding increased from Dec. 2022 (56.42) to Dec. 2023 (69.02).

Genscript Biotech Days Sales Outstanding Historical Data

The historical data trend for Genscript Biotech's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genscript Biotech Days Sales Outstanding Chart

Genscript Biotech Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

90.27

98.95

102.81

67.77

66.89

Genscript Biotech Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial														77.58	68.40	56.42	52.21	69.02

Competitive Comparison of Genscript Biotech's Days Sales Outstanding

For the Biotechnology subindustry, Genscript Biotech's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Genscript Biotech's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Genscript Biotech's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Genscript Biotech's Days Sales Outstanding falls into.

Genscript Biotech Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Genscript Biotech's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (754.654	+	1648.625)	/	2 )	/	6556.554	*	365
=	1201.6395					/	6556.554	*	365
=	66.89

Genscript Biotech's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (999.248	+	1648.625)	/	2 )	/	3500.493	*	365 / 2
=	1323.9365					/	3500.493	*	365 / 2
=	69.02

Genscript Biotech (HKSE:01548) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Genscript Biotech Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Genscript Biotech's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Genscript Biotech (HKSE:01548) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genscript Biotech Corp (HKSE:01548) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

GNNSF:USA G51:Germany

Address

No. 28, Yongxi Road, Jiangning Science Park, Jiangsu Province, Nanjing, CHN, 211100

Website

https://www.genscript.com

GenScript Biotech is a China-based provider of life science research services and products. Founded in 2002, it is best known for its gene synthesis capabilities, a widely used service by academics, biotech companies, and pharmaceutical companies around the world. Its business lines include life science research services and products, biologics development services under its ProBio brand, and industrial enzymes under its Bestzyme brand. Finally, it owns 57.1% of Nasdaq-listed Legend Biotech, whose key pipeline asset is a BCMA-targeting CAR-T treatment for multiple myeloma. We estimate that more than two thirds of GenScript's valuation is from its ownership stake in Legend.

Genscript Biotech (HKSE:01548) Headlines

No Headlines